Infections in solid organ transplant HIV-infected patients

Clinical Microbiology and Infection

Volumn 20, Issue s7, 2014, Pages 119-130

  Miro, J M ^a   Aguero F ^a   Duclos Vallee J C ^b,c,d,e   Mueller, N J ^f   Grossi, P ^g   Moreno, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b AP HP Hôpital Paul Brousse   (Switzerland)

^c Inserm   (Switzerland)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e DHU Hepatinov   (Switzerland)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^g UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

End stage organ disease; Hepatitis B virus; Hepatitis C virus; Highly active antiretroviral therapy; HIV AIDS; Infections; Prophylaxis of opportunistic infections; Solid organ transplantation

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; IMMUNOSUPPRESSIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIAL INFECTION; DISEASE TRANSMISSION; END STAGE LIVER DISEASE; EUROPE; GRAFT INFECTION; GRAFT RECIPIENT; HEART; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; KIDNEY; LIVER; LUNG; OPPORTUNISTIC INFECTION; ORGAN DONOR; ORGAN TRANSPLANTATION; PANCREAS; SOLID ORGAN TRANSPLANTATION; IMMUNOCOMPROMISED PATIENT; INFECTION CONTROL; NORTH AMERICA; OPPORTUNISTIC INFECTIONS; PROCEDURES;

EUROPE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFECTION CONTROL; NORTH AMERICA; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION; TRANSPLANT RECIPIENTS;

EID: 84908216935     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12754     Document Type: Review

References (92)

1. Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet 2010; 376: 49-62.
2. Aguero F, Laguno M, Moreno A, Rimola A, Miro JM. Management of end-stage liver disease in HIV-infected patients. Curr Opin HIV AIDS 2007; 2: 474-481.
3. Miro JM, Aguero F, Laguno M et al. Liver transplantation in HIV/hepatitis co-infection. J HIV Ther 2007; 12: 24-35.
4. Trullas JC, Cofan F, Tuset M et al. Renal transplantation in HIV-infected patients: 2010 update. Kidney Int 2011; 79: 825-842.
5. Miro JM, Torre-Cisnero J, Moreno A et al. GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005). Enferm Infecc Microbiol Clin 2005; 23: 353-362.
6. Duclos-Vallee JC, Feray C, Sebagh M et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008; 47: 407-417.
7. Miro JM, Montejo M, Castells L et al. Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study. Am J Transplant 2012; 12: 1866-1876.
8. Terrault NA, Roland ME, Schiano T et al. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl 2012; 18: 716-726.
9. Stock PG, Barin B, Murphy B et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 2010; 363: 2004-2014.
10. Coffin CS, Stock PG, Dove LM et al. Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. Am J Transplant 2010; 10: 1268-1275.
11. Castel MA, Perez-Villa F, Miro JM. Heart transplantation in HIV-infected patients: more cases in Europe. J Heart Lung Transplant 2011; 30: 1418.
12. Grossi PA, Righi E, Gasperina DD et al. Report of four simultaneous pancreas-kidney transplants in HIV-positive recipients with favorable outcomes. Am J Transplant 2012; 12: 1039-1045.
13. Bertani A, Grossi P, Vitulo P et al. Successful lung transplantation in an HIV- and HBV-positive patient with cystic fibrosis. Am J Transplant 2009; 9: 2190-2196.
14. Hamers FF, Downs AM. The changing face of the HIV epidemic in western Europe: what are the implications for public health policies? Lancet 2004; 364: 83-94.
15. Rockstroh JK, Mocroft A, Soriano V et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005; 192: 992-1002.
16. Konopnicki D, Mocroft A, De WS et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19: 593-601.
17. Gonzalez-Garcia JJ, Mahillo B, Hernandez S et al. Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study. Enferm Infecc Microbiol Clin 2005; 23: 340-348.
18. Trullas JC, Mocroft A, Cofan F et al. Dialysis and renal transplantation in HIV-infected patients: a European survey. J Acquir Immune Defic Syndr 2010; 55: 582-589.
19. Grossi PA. Update in HIV infection in organ transplantation. Curr Opin Organ Transplant 2012; 17: 586-593.
20. Fox AN, Vagefi PA, Stock PG. Liver transplantation in HIV patients. Semin Liver Dis 2012; 32: 177-185.
21. O'Grady J, Taylor C, Brook G. Guidelines for liver transplantation in patients with HIV infection (2005). HIV Med 2005; 6(suppl 2): 149-153.
22. Duclos-Vallee JC, Tateo M, Teicher E et al. Results of liver transplantation in a large cohort of more than 100 HIV infected patients - a monocentric experience. Liver Transpl 2011; 17 (suppl S1): S80.
23. Roland ME, Stock PG. Liver transplantation in HIV-infected recipients. Semin Liver Dis 2006; 26: 273-284.
24. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at http://aidsinfo.nih.gov/guidelines. (Accessed June 5, 2014).
25. Frassetto L, Floren L, Barin B et al. Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients. Biopharm Drug Dispos 2013; 34: 442-451.
26. Deeks ED. Cobicistat: a review of its use as a pharmacokinetic enhancer of atazanavir and darunavir in patients with HIV-1 infection. Drugs 2013; 74: 195-206.
27. Perry CM. Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Stribild((R))): a review of its use in the management of HIV-1 infection in adults. Drugs 2014; 74: 75-97.
28. Antonini TM, Furlan V, Teicher E et al. Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft. AIDS 2013; 27: 2655-2657.
29. Miro JM, Manzardo C, Brunet M et al. Combination of Raltegravir Plus Lamivudine or Emtricitabine Plus Abacavir or Tenofovir is Safe, Effective and Prevents Pharmacokinetic Interactions With Immunosuppressive Drugs in HIV-infected Solid Organ Transplant Recipients. CROI 2011, Boston, Feb 27- Mar 2, 2011. Abstract N-131.
30. Moreno A, Quereda C, Montes M et al. Safe coadministration of raltegravir-based HAART in HIV-infected patients with HCV-cirrhosis receiving triple therapy with telaprevir or boceprevir. J Acquir Immune Defic Syndr 2012a; 61: e47-e49.
31. Tricot L, Teicher E, Peytavin G et al. Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant 2009; 9: 1946-1952.
32. Castellino S, Moss L, Wagner D et al. Metabolism, excretion, and mass balance of the HIV-1 integrase inhibitor dolutegravir in humans. Antimicrob Agents Chemother 2013; 57: 3536-3546.
33. Toronto General Hospital's Hepatitis C Drug Information Web site. Antiretroviral Treatment Options for Patients on DAAs - Summary. Available at: http://www.hcvdruginfo.ca. Accessed (June 5, 2014).
34. Karageorgopoulos DE, El-Sherif O, Bhagani S, Khoo SH. Drug interactions between antiretrovirals and new or emerging direct-acting antivirals in HIV/hepatitis C virus coinfection. Curr Opin Infect Dis 2014; 27: 36-45.
35. Back D, Gibbons S. The University of Liverpool HIV drug interactions website. http://www.hiv-druginteractions.org/. Accessed (June 5, 2014).
36. Tuset M, Miró JM, Codina C, Ribas J. Guía de interacciones en HIV. http://www.interaccionesvih.com. Accessed (June 5, 2014).
37. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for disease Control and Prevention, the National Institutes of Health, and the HIV Medical Association of the Infectious Diseases Society of America. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed (June 5, 2014).
38. Mocroft A, Reiss P, Kirk O et al. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL? Clin Infect Dis 2010; 51: 611-619.
39. Danzinger-Isakov L, Kumar D. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2009; 9(suppl 4): S258-S262.
40. Gavalda J, Vidal E, Lumbreras C. Infection prevention in solid organ transplantation. Enferm Infecc Microbiol Clin 2012; 30(suppl 2): 27-33.
41. Aguado JM, Torre-Cisneros J, Fortun J et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48: 1276-1284.
42. Rubin LG, Levin MJ, Ljungman P et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2013; 58: 309-318.
43. Bratzler DW, Dellinger EP, Olsen KM et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013; 70: 195-283.
44. Tornero E, Morata L, Martinez-Pastor JC, Bori G, Mensa J, Soriano A. Prosthetic joint infections due to methicillin-resistant and methicillin-susceptible staphylococci treated with open debridement and retention of the prosthesis. Rev Esp Quimioter 2013; 26: 353-359.
45. Jimenez-Exposito MJ, Mestres CA, Claramonte X et al. Mortality and morbidity in HIV-infected patients undergoing coronary artery bypass surgery: a case control study. Rev Esp Cardiol 2006; 59: 276-279.
46. Mazuecos A, Fernandez A, Andres A et al. HIV infection and renal transplantation. Nephrol Dial Transplant 2011; 26: 1401-1407.
47. Roland ME, Adey D, Carlson LL, Terrault NA. Kidney and liver transplantation in HIV-infected patients: case presentations and review. AIDS Patient Care STDS 2003; 17: 501-507.
48. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58: 1-207.
49. Vernadakis S, Sotiropoulos GC, Brokalaki EI et al. Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experience. Eur J Med Res 2011; 16: 342-348.
50. Roland ME, Barin B, Carlson L et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008; 8: 355-365.
51. Di Benedetto F, Tarantino G, De Ruvo N et al. University of Modena experience in HIV-positive patients undergoing liver transplantation. Transplant Proc 2011; 43: 1114-1118.
52. Cherian PT, Alrabih W, Douiri A et al. Liver transplantation in human immunodeficiency virus-infected patients: procoagulant, but is antithrombotic prophylaxis required? Liver Transpl 2012; 18: 82-88.
53. Moreno A, Cervera C, Fortun J et al. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis c virus-coinfected liver transplant recipients: a FIPSE/GESIDA Prospective Cohort Study. Liver Transpl 2012b; 18: 70-81.
54. Malhotra P, Rai SD, Hirschwerk D. Duration of prophylaxis with trimethoprim-sulfamethoxazole in patients undergoing solid organ transplantation. Infection 2012; 40: 473-475.
55. Landin L, Rodriguez-Perez JC, Garcia-Bello MA et al. Kidney transplants in HIV-positive recipients under HAART. A comprehensive review and meta-analysis of 12 series. Nephrol Dial Transplant 2010; 25: 3106-3115.
56. Fischer SA, Avery RK. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant 2009; 9(suppl 4): S7-S18.
57. Muller E, Kahn D, Mendelson M. Renal transplantation between HIV-positive donors and recipients. N Engl J Med 2010; 362: 2336-2337.
58. Cofan F, Trullas JC, Cervera C et al. Are HIV-infected donors suitable for renal transplantation? Transplantation 2011; 91: e22-e23.
59. Boyarsky BJ, Hall EC, Singer AL, Montgomery RA, Gebo KA, Segev DL. Estimating the potential pool of HIV-infected deceased organ donors in the United States. Am J Transplant 2011; 11: 1209-1217.
60. Mgbako O, Glazier A, Blumberg E, Reese PP. Allowing HIV-positive organ donation: ethical, legal and operational considerations. Am J Transplant 2013; 13: 1636-1642.
61. Reardon S. United States to allow transplants of HIV-infected organs. Nature News. Available at http://www.nature.com/news/united-states-to-allow-transplants-of-hiv-infected-organs-1.14170. Accessed (June 5, 2014).
62. Muller E, Barday Z, Mendelson M, Kahn D. Renal transplantation between HIV-positive donors and recipients justified. S Afr Med J 2012; 102: 497-498.
63. Malani PN. New law allows organ transplants from deceased HIV-infected donors to HIV-infected recipients. JAMA 2013; 310: 2492-2493.
64. Tzakis AG, Cooper MH, Dummer JS, Ragni M, Ward JW, Starzl TE. Transplantation in HIV+ patients. Transplantation 1990; 49: 354-358.
65. Baccarani U, Adani GL, Bragantini F et al. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases. Transplant Proc 2011; 43: 1119-1122.
66. Schreibman I, Gaynor JJ, Jayaweera D et al. Outcomes after orthotopic liver transplantation in 15 HIV-infected patients. Transplantation 2007; 84: 697-705.
67. de Vera ME, Dvorchik I, Tom K et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant 2006; 6: 2983-2993.
68. Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003; 75: 425-429.
69. Panel of Experts of GESIDA and Spanish Secretariat for the National Plan on AIDS. Executive summary of the Consensus Document of GeSIDA and Spanish Secretariat for the National Plan on AIDS on combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2013). Enferm Infecc Microbiol Clin 2013; 31: 604-613.
70. Thompson MA, Aberg JA, Hoy JF et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 2012; 308: 387-402.
71. Price P, Mathiot N, Krueger R, Stone S, Keane NM, French MA. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol 2001; 22: 279-287.
72. Grossi P, Tumietto F, Gabbrielli F, Venettoni S, Rizzato L, Costa A. Liver transplantation in HIV-infected individuals: Results of the Italian National Program. Transpl Int 2005; 18 (S1): 11.
73. Anonymous . Solid organ transplantation in the HIV-infected patient. Am J Transplant 2004; 4 (suppl 10): 83-88; 1.
74. Beatty S, Barin B, Fox L et al. HIV-related predictors and outcomes in 275 liver and/or kidney transplant recipients. 2011. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome, 2011.
75. Teicher E, Duclos-Vallee JC. Opportunistic infections after liver transplantation in patients infected with human immunodeficiency virus. Liver Transpl 2012; 18: 376-377.
76. Duclos-Vallee JC, Falissard B, Samuel D. Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with a synthetic cohort. AIDS 2011b; 25: 1675-1676.
77. Antonini TM, Sebagh M, Roque-Afonso AM et al. Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantation. Am J Transplant 2011; 11: 1686-1695.
78. Asensio A, Ramos A, Cuervas-Mons V et al. Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant. Liver Transpl 2008; 14: 799-805.
79. Garrido RS, Aguado JM, Diaz-Pedroche C et al. A review of critical periods for opportunistic infection in the new transplantation era. Transplantation 2006; 82: 1457-1462.
80. Peleg AY, Husain S, Kwak EJ et al. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis 2007; 44: 204-212.
81. Nichols L, Ocque RZ, Daly I. Zygomycosis associated with HIV infection and liver transplantation. Patholog Res Int 2011; 2011: 545981.
82. Ragni MV, Belle SH, Im K et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003; 188: 1412-1420.
83. Di Benedetto F, Di Sandro S, De Ruvo N et al. Human immunodeficiency virus and liver transplantation: our point of view. Transplant Proc 2008; 40: 1965-1971.
84. Vennarecci G, Ettorre GM, Antonini M, et al. Liver transplantation in HIV-positive patients. Transplant Proc 2007; 39: 1936-1938.
85. Touzot M, Pillebout E, Matignon M et al. Renal transplantation in HIV-infected patients: the Paris experience. Am J Transplant 2010; 10: 2263-2269.
86. Stallone G, Schena A, Infante B et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005; 352: 1317-1323.
87. Trullas JC, Cofan F, Cocchi S et al. Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients. AIDS Res Hum Retroviruses 2007; 23: 1161-1165.
88. + T-cell depletion and infection risk in HIV-infected renal transplant recipients. Am J Transplant 2006; 6: 753-760.
89. Fung J, Eghtesad B, Patel-Tom K, DeVera M, Chapman H, Ragni M. Liver transplantation in patients with HIV infection. Liver Transpl 2004; 10: S39-S53.
90. Uriel N, Jorde UP, Cotarlan V et al. Heart transplantation in human immunodeficiency virus-positive patients. J Heart Lung Transplant 2009; 28: 667-669.
91. Miro JM, Ricart MJ, Trullas JC et al. Simultaneous pancreas-kidney transplantation in HIV-infected patients: a case report and literature review. Transplant Proc 2010; 42: 3887-3891.
92. Anonymous . 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41: 1-19.